Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04114968
Other study ID # 2702
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 30, 2019
Est. completion date December 31, 2025

Study information

Verified date November 2020
Source University of Aarhus
Contact Mette Tranberg, Post doc PhD
Phone +45 784 20264
Email mettrani@rm.dk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the effect and feasibility of expanding the target population in the Danish cervical cancer screening program to include women aged 65 to 69 years. The study also evaluates if HPV self-sampling constitutes an appropriate screening method among older women.


Description:

The study is a nationwide population-based prospective cohort study embedded in the routine cervical cancer screening program in the Central Denmark Region. The study includes all 65 to 69 years old Danish women with no record of a cervical cytology sample or screening invitation within the last five years. Furthermore, the women are not registered as ineligible for screening, eg due hysterectomy. Eligible women residing in the Central Denmark Region are allocated to the intervention group (n=20,000), while women residing in the other four Danish regions are allocated to the control group receiving standard care (n=71,500), which for this group is low-level opportunistic screening at the general practitioner (GP). The intervention group are invited for HPV-based screening by the GP or to request a self-sampling kit.


Recruitment information / eligibility

Status Recruiting
Enrollment 20000
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers
Gender Female
Age group 65 Years to 69 Years
Eligibility Inclusion Criteria: - 65 to 69 years; - Resident in Denmark - No record of a cervical cytology or screening invitation in the past 5 years - Not registered as ineligible for screening Exclusion Criteria: - Death - Migration to or from Denmark - Moving to or from the CDR - Residing in the CDR, but having GP in another region - A record of hysterectomy

Study Design


Intervention

Other:
GP-based screening or HPV self-sampling
Women in the intervention group will receive an invitation for HPV-based cervical cancer screening by either 1) scheduling an appointment for a cervical cytology by the GP or 2) collect a cervico-vaginal sample themselves in their own home using a self-sampling kit.

Locations

Country Name City State
Denmark Mette Tranberg Nielsen Randers Randers NØ

Sponsors (1)

Lead Sponsor Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Participation rate in the intervention group: Participation rate, eg the roportion of targeted women participating by GP-based screening or self-sampling 1 year post invitation
Primary HPV prevalence Number of women tested positive for HPV 1 year post invitation
Primary Compliance to follow-up among HPV-positive self-samplers The proportion of HPV-positive self-samplers who attend appropriate follow-up by their GP for onward referral 90 days post test results
Primary Screening history Screening history of participants and non-participants in the intervention group Average of 10 years
Primary Intervention versus control group: Participation rate 1 year post invitation
Primary Cytological findings Proportion of abnormal cytological findings between the intervention and control group is compared 1 year post invitation
Primary Histological findings Proportion of abnormal histological findings between the intervention and control group is compared 1 year post invitation
Primary Incidence The incidence rate of cervical cancer developed within 5 year is compared between the intervention and control group 5 year post invitation
Primary Mortality The mortality rate of cervical cancer developed within 5 year is compared between the intervention and control group 5 year post invitation
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04343950 - SMS Messaging as a Tool to Improve Cancer Screening Programs N/A
Completed NCT05022511 - Three Birds With One Stone N/A
Recruiting NCT03988322 - Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China N/A
Completed NCT03225560 - Smart Phone App for COLOnoscopic PREParation N/A
Recruiting NCT03992833 - Methods of Computed Tomography Screening and Management of Lung Cancer N/A
Active, not recruiting NCT03583840 - Effectiveness of a Web-based Intervention to Promote Health Screening in Men N/A
Completed NCT01226173 - Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol N/A
Completed NCT00229554 - Survey of ColoRectal Cancer Education and Environment Needs N/A
Completed NCT03979144 - Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening
Completed NCT04941209 - imPulseā„¢ Una Infrasound-to-ultrasound E-stethoscope
Not yet recruiting NCT04947930 - Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
Completed NCT04432753 - Effect of Incidental Findings Information on Lung Cancer Screening Intent N/A
Active, not recruiting NCT04527510 - Remote Breast Cancer Screening Study
Completed NCT00283127 - Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and Women. N/A
Completed NCT00308568 - RCT of Mailed Brochure to Boost Adherence to Screening Colonoscopy N/A
Recruiting NCT04684355 - Quality of Life of Colorectal Cancer Screenees in the Period Between Colonoscopy and Next Clinic Visit for Final Report: Does Real-time Endoscopic Optical Diagnosis Improve Their Quality of Life N/A
Enrolling by invitation NCT03395509 - The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases
Completed NCT03122275 - Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer N/A
Completed NCT05163236 - Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening